Literature DB >> 899741

Post-irradiation pituitary sarcoma.

H C Powell, L F Marshall, R J Ignelzi.   

Abstract

A fibrosarcoma developed in the pituitary fossa of a patient who had been irradiated 13 years previously for treatment of pituitary adenoma. The tumor was a large aggressively growing spindle cell neoplasm which eroded adjacent structures, causing increased intracranial pressure, and eventual cerebellar tonsillar herniation. In common with previously described post-irradiation sarcoma of the pituitary, this lesion developed in the path of irradiation after a long latent period, did not metastasize, and contained histologically recognizable benign appearing pituitary adenoma interspersed among the spindle cell tumor. The dose of radiation (5000 rads) also lay within the range associated with sarcomatous transformation.

Entities:  

Mesh:

Year:  1977        PMID: 899741     DOI: 10.1007/bf00703323

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  PITUITARY SARCOMA; A POSSIBLE CONSEQUENCE OF RADIATION.

Authors:  A H GREENHOUSE
Journal:  JAMA       Date:  1964-10-26       Impact factor: 56.272

2.  Combined nonmetastasizing fibrosarcoma and chromophobe tumor of the pituitary.

Authors:  R D TERRY; V J HYAMS; L M DAVIDOFF
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

3.  Primary carcinoma of the pituitary.

Authors:  T H NEWTON; H J BURHENNE; A J PALUBINSKAS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-01

4.  Osteogenic sarcoma of the skull: a rare sequela of pituitary irradition.

Authors:  M Sparagana; R W Eells; S Stefani; V Jablokow
Journal:  Cancer       Date:  1972-05       Impact factor: 6.860

5.  Sarcoma: a possible late result of effective radiation therapy for pituitary adenoma. Report of two cases.

Authors:  T A Waltz; B Brownell
Journal:  J Neurosurg       Date:  1966-05       Impact factor: 5.115

6.  The radiotherapy of pituitary chromophobe adenomas: an evaluation of indication, technic, and result.

Authors:  C H Chang; J L Pool
Journal:  Radiology       Date:  1967-12       Impact factor: 11.105

  6 in total
  8 in total

Review 1.  Pituitary tumors: prognostic indicators.

Authors:  Wolfgang Saeger
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

2.  Radiation-induced meningeal and pituitary tumors in the rat after prenatal application of strontium-90.

Authors:  W Schmahl; W E Kollmer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma.

Authors:  E Ciccarelli; M R Valetto; E Vasario; T Avataneo; S Grottoli; F Camanni
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

Review 4.  Sarcomas of the sellar region: a systematic review.

Authors:  Fernando Guerrero-Pérez; Noemi Vidal; Macarena López-Vázquez; Reinaldo Sánchez-Barrera; Juan José Sánchez-Fernández; Alberto Torres-Díaz; Nuria Vilarrasa; Carles Villabona
Journal:  Pituitary       Date:  2021-02       Impact factor: 4.107

Review 5.  Combined sellar fibrosarcoma and prolactinoma with neuronal metaplasia: report of a case unassociated with radiotherapy.

Authors:  Mario Moro; Caterina Giannini; Bernd W Scheithauer; Ricardo V Lloyd; Paul Restall; Carl Eagleton; Andrew J Law; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 6.  Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review.

Authors:  Ryuya Yamanaka; Eisuke Abe; Toshiteru Sato; Azusa Hayano; Yasuo Takashima
Journal:  Cancers (Basel)       Date:  2017-08-08       Impact factor: 6.639

7.  An aortic body carcinoma with sarcomatoid morphology and chondroid metaplasia in a French Bulldog.

Authors:  Chiaki Morita; Miyuu Tanaka; Shunsuke Noguchi; Shunsuke Shimamura; Yusuke Wada; Takeshi Izawa; Jyoji Yamate; Mitsuru Kuwamura
Journal:  J Vet Med Sci       Date:  2020-03-12       Impact factor: 1.267

8.  Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib.

Authors:  Daniela Alexandru; Denise K Van Horn; Daniela Annenelie Bota
Journal:  J Neurooncol       Date:  2009-12-31       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.